AMBRISENTAN for Chronic obstructive pulmonary disease: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 460 adverse event reports in the FDA FAERS database where AMBRISENTAN was used for Chronic obstructive pulmonary disease.
Most Reported Side Effects for AMBRISENTAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 13,367 | 15.5% | 652 | 6,217 |
| Death | 7,497 | 8.7% | 7,442 | 1,241 |
| Headache | 7,325 | 8.5% | 203 | 1,884 |
| Pneumonia | 4,693 | 5.4% | 368 | 3,802 |
| Dizziness | 4,561 | 5.3% | 93 | 1,261 |
| Fatigue | 4,436 | 5.2% | 145 | 1,312 |
| Diarrhoea | 4,312 | 5.0% | 168 | 1,512 |
| Nausea | 3,986 | 4.6% | 153 | 1,297 |
| Fluid retention | 3,927 | 4.6% | 212 | 2,212 |
| Malaise | 3,839 | 4.5% | 214 | 1,491 |
| Peripheral swelling | 3,461 | 4.0% | 128 | 1,107 |
| Cough | 3,067 | 3.6% | 85 | 899 |
| Nasal congestion | 3,019 | 3.5% | 36 | 423 |
| Oedema peripheral | 2,959 | 3.4% | 114 | 882 |
| Oedema | 2,651 | 3.1% | 109 | 923 |
Other Indications for AMBRISENTAN
Product used for unknown indication (35,884)
Pulmonary arterial hypertension (27,852)
Pulmonary hypertension (18,885)
Scleroderma (1,547)
Cor pulmonale chronic (879)
Connective tissue disorder (857)
Heart disease congenital (772)
Portopulmonary hypertension (428)
Sleep apnoea syndrome (352)
Systemic lupus erythematosus (345)
Other Drugs Used for Chronic obstructive pulmonary disease
TIOTROPIUM (20,175)
FLUTICASONE\SALMETEROL (8,896)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (8,730)
ALBUTEROL (8,572)
BUDESONIDE\FORMOTEROL (6,539)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (4,580)
UMECLIDINIUM\VILANTEROL TRIFENATATE (4,512)
DUPILUMAB (3,526)
ALBUTEROL\IPRATROPIUM (3,289)
ACLIDINIUM (2,321)